Amager Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00130455
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Amager- and Hvidovre Hospital, Denmark | Amager Hospital | Department of Occupational and Physical Therapy and Department of Orthopedic Surgery, Amager-Hvidovre University Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

escitalopram (lexapro) (1 trial)

Drugs in Phase 2 Trials (2)

nandrolone phenpropionate (durabolin) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Fractures, Bone (Phase 2)

Hip Fractures (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3